Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)
Clinical trial NCT07282457 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07282457
- Sponsor
- Zhongmou Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-25
- Primary completion
- 2029-12-25
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.